BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica

NCT04027101 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Polymyalgia Rheumatic (PMR)

Interventions

DRUG: Baricitinib
DRUG: Placebos

Sponsor

University Hospital, Brest

Collaborators

[object Object]